Evidence map›Paper›PMID 25302077›Full record

ArticleGenome medicine2014

Evolutionarily conserved genetic interactions with budding and fission yeast MutS identify orthologous relationships in mismatch repair-deficient cancer cells.

Elena Tosti, Joseph A Katakowski, Sonja Schaetzlein, Hyun-Soo Kim, Colm J Ryan, Michael Shales, Assen Roguev, Nevan J Krogan, Deborah Palliser, Michael-Christopher Keogh and 1 more

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Elena TostiDepartment of Cell Biology, Albert Einstein College of Medicine, New York, USA.
Joseph A KatakowskiDepartment of Microbiology & Immunology, Albert Einstein College of Medicine, New York, USA.
Sonja SchaetzleinDepartment of Cell Biology, Albert Einstein College of Medicine, New York, USA.
Hyun-Soo KimDepartment of Cell Biology, Albert Einstein College of Medicine, New York, USA.
Colm J RyanDepartment of Cellular & Molecular Pharmacology, UCSF, San Francisco, USA ; California Institute for Quantitative Biosciences, San Francisco, USA ; School of Medicine and Medical Science, University College Dublin, Dublin, Ireland.
Michael ShalesDepartment of Cellular & Molecular Pharmacology, UCSF, San Francisco, USA.
Assen RoguevDepartment of Cellular & Molecular Pharmacology, UCSF, San Francisco, USA.
Nevan J KroganDepartment of Cellular & Molecular Pharmacology, UCSF, San Francisco, USA ; California Institute for Quantitative Biosciences, San Francisco, USA ; J. David Gladstone Institutes, San Francisco, USA.
Deborah PalliserDepartment of Microbiology & Immunology, Albert Einstein College of Medicine, New York, USA.
Michael-Christopher KeoghDepartment of Cell Biology, Albert Einstein College of Medicine, New York, USA.
Winfried EdelmannDepartment of Cell Biology, Albert Einstein College of Medicine, New York, USA.
Albert Einstein College of Medicine · USUniversity of California, San Francisco · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
DNA MISMATCH REPAIR AND CANCER IN MURINE MODELSR01CA076329 · NCI · YESHIVA UNIVERSITY · PI EDELMANN, WINFRIED · 1998 to 2017
$6.9M
The Role of Late MMR Proteins in DNA Repair and CancerR01CA093484 · NCI · YESHIVA UNIVERSITY · PI EDELMANN, WINFRIED · 2002 to 2011
$3.7M
Enhancing RNAi delivery in vivoR01AI099567 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI LAUVAU, GREGOIRE STEPHANE · 2012 to 2016
$2.1M
Dissecting HSV-2 immunity using cell-targeted siRNAsR21AI093539 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI PALLISER, DEBORAH · 2011 to 2012
$457k
Identifying Conserved Genetic Networks for Eukaryotic MMR GenesR21ES019966 · NIEHS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI EDELMANN, WINFRIED · 2011 to 2012
$457k
NCI NIH HHS P30 CA013330NCI NIH HHS R01 CA076329NCI NIH HHS R01 CA093484NIAID NIH HHS R01 AI099567NIAID NIH HHS R21 AI093539NIEHS NIH HHS R21 ES019966
6 · The paper itself

Abstract

backgroundThe evolutionarily conserved DNA mismatch repair (MMR) system corrects base-substitution and insertion-deletion mutations generated during erroneous replication. The mutation or inactivation of many MMR factors strongly predisposes to cancer, where the resulting tumors often display resistance to standard chemotherapeutics. A new direction to develop targeted therapies is the harnessing of synthetic genetic interactions, where the simultaneous loss of two otherwise non-essential factors leads to reduced cell fitness or death. High-throughput screening in human cells to directly identify such interactors for disease-relevant genes is now widespread, but often requires extensive case-by-case optimization. Here we asked if conserved genetic interactors (CGIs) with MMR genes from two evolutionary distant yeast species (Saccharomyces cerevisiae and Schizosaccharomyzes pombe) can predict orthologous genetic relationships in higher eukaryotes.

methodsHigh-throughput screening was used to identify genetic interaction profiles for the MutSα and MutSβ heterodimer subunits (msh2Δ, msh3Δ, msh6Δ) of fission yeast. Selected negative interactors with MutSβ (msh2Δ/msh3Δ) were directly analyzed in budding yeast, and the CGI with SUMO-protease Ulp2 further examined after RNA interference/drug treatment in MSH2-deficient and -proficient human cells.

resultsThis study identified distinct genetic profiles for MutSα and MutSβ, and supports a role for the latter in recombinatorial DNA repair. Approximately 28% of orthologous genetic interactions with msh2Δ/msh3Δ are conserved in both yeasts, a degree consistent with global trends across these species. Further, the CGI between budding/fission yeast msh2 and SUMO-protease Ulp2 is maintained in human cells (MSH2/SENP6), and enhanced by Olaparib, a PARP inhibitor that induces the accumulation of single-strand DNA breaks. This identifies SENP6 as a promising new target for the treatment of MMR-deficient cancers.

conclusionOur findings demonstrate the utility of employing evolutionary distance in tractable lower eukaryotes to predict orthologous genetic relationships in higher eukaryotes. Moreover, we provide novel insights into the genome maintenance functions of a critical DNA repair complex and propose a promising targeted treatment for MMR deficient tumors.

Identifiers

PMID25302077
PMCPMC4189729
OpenAlexW2134628914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.